Depression Among Adults With Diabetes: Prevalence, Impact, and Treatment Options
Patients with type 1 or type 2 diabetes are two times more likely to experience depression than their peers without diabetes. Comorbid depression results in deleterious effects on glycemic control, worsened diabetes complications, functional disability, and premature mortality. Once identified, depression can be effectively treated with antidepressant medications, psychotherapy, or a combination of both. Patients and providers should monitor depressive symptoms to identify their recurrence and work collaboratively to address barriers to care that exist in both urban and rural areas.
Mary de Groot, PhD, is an associate professor in the Department of Medicine at the Indiana University School of Medicine in Indianapolis. Michael Kushnick, PhD, is an associate professor, and Mark McGlynn, BA, is a graduate student at the Ohio University School of Recreation and Sport Sciences in Athens. Todd Doyle, MS, and Jennifer Merrill, MS, are graduate students at the Ohio University Department of Psychology in Athens. Jay Shubrook, DO, is an associate professor, and Frank Schwartz, MD, is a professor at the Ohio University College of Osteopathic Medicine in Athens.
- American Diabetes Association(R) Inc., 2010